Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
45,776,780
-
Share change
-
+4,934,068
-
Total reported value
-
$114,440,440
-
Put/Call ratio
-
292%
-
Price per share
-
$2.50
-
Number of holders
-
68
-
Value change
-
+$11,771,388
-
Number of buys
-
42
-
Number of sells
-
24
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2019
As of 30 Jun 2019,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,776,780 shares.
The largest 10 holders included
NEA Management Company, LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., BOXER CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BVF INC/IL, CAXTON CORP, and MILLENNIUM MANAGEMENT LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.